Compliance Sweep, week of Aug 23, 2026

Treasury, Labor, HHS and OPM published a correcting amendment on August 28 to their June 4 Federal Independent Dispute Resolution Operations final rule. The correction repairs omissions and references in the parallel tax, labor and health-insurance regulations. It became effective August 28 and applies beginning August 3, the original rule’s effective date. The departments reproduce the payment-determination paragraph in full because the earlier text was incomplete, rather than treating the missing text as an issue only for future disputes.

The restored language makes a certified IDR entity’s determination binding unless fraud or intentional misrepresentation of material claim facts is involved, and preserves the specified limited grounds for judicial review under federal arbitration law. Other edits remove an inadvertently retained word and repair references between procedural provisions. The departments describe these changes as corrections to the policies already established through notice and comment, invoking good cause rather than opening another proposal. For organizations handling out-of-network payment disputes, the practical distinction is between unchanged policy intent and the corrected regulatory text that submissions and vendor procedures actually cite.

CDPH’s August 27 All Facilities Letter 26-28 explains SB 164, Chapter 27, and the home health agency licensing moratorium that began June 29. The moratorium lasts until no later than 90 days after the required revised regulations take effect. It bars new initial licenses and branch approvals unless CDPH makes the specified written unmet-need finding based on existing services in the proposed area. Applications not licensed by June 29 stop processing. CDPH is contacting those applicants: by October 9 they must indicate withdrawal, provide an exception justification and supporting documentation, or state the applicable intent to continue a change-of-ownership process. Without the required response, CDPH automatically withdraws the application. Ownership changes within five years of initial licensure need an exception for continuity of care or both financial hardship and unmet geographic need. New applicants should seek an exception before applying; ordinary renewals and specified changes that do not expand the service area remain outside the moratorium.

The letter separately requires an administrator and designee and a director of patient care services and designee. Their HS 215A or successor forms, resumes and current management roles must be submitted at application, within ten business days of a personnel change, and once for currently licensed agencies by March 31, 2027. Parent-agency branch offices are exempt from those management filings. Private-agency applicants must provide fingerprints for people with at least a five-percent ownership interest. Expanded licensing-action grounds include specified prior Medicare or Medi-Cal termination or license action, a pattern of violations within three years, applicant or licensee exclusion-list status, management noncooperation with inspections or complaints, and unreported ownership, personnel, service-area or location changes. CDPH also cannot renew a provisional license that lacks the required full-licensure standards. These personnel, ownership and enforcement provisions require separate review from an application’s moratorium exception.

HHS published its vaccine-recommendation request for information on August 24 under docket HHS-OS-2026-0332, with comments due September 20. It asks whether routine, risk-based and shared clinical decision-making categories remain adequate, or whether additional or different categories would be clearer. In the framework described by the notice, routine recommendations generally make vaccination the default absent contraindications; risk-based recommendations address specified risk groups; shared decision-making turns on individual circumstances, clinical judgment and patient or parent preferences. The request itself adopts no replacement framework.

The questions extend beyond category names. HHS asks how scientific evidence, gaps in randomized-trial evidence, autonomy, religious freedom and communication should affect recommendations, and what category changes could mean for coverage, access and other legal or program consequences. It also asks how to prevent shared decision-making from being misunderstood as loss of coverage or vaccine availability. The notice explicitly states that it is neither a rule nor a recommendation and changes no existing recommendation, coverage requirement or program obligation. Organizations considering comments can therefore identify concrete problems in category-dependent order sets or patient materials without presenting the consultation as an already effective change.